Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.5 GBX | 0.00% | -7.27% | +64.52% |
Apr. 18 | Renalytix chief business officer to become president | AN |
Apr. 18 | Renalytix Names Chief Business Officer as President | MT |
Financials (USD)
Sales 2024 * | 4M | Sales 2025 * | 18M | Capitalization | 49.26M |
---|---|---|---|---|---|
Net income 2024 * | -35M | Net income 2025 * | -26M | EV / Sales 2024 * | 12.3 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.74 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.28% |
Latest transcript on Renalytix Plc
1 week | -7.27% | ||
Current month | +18.60% | ||
1 month | -13.56% | ||
3 months | +82.14% | ||
6 months | -32.89% | ||
Current year | +64.52% |
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 18-03-14 |
James Sterling
DFI | Director of Finance/CFO | 54 | 18-03-14 |
Howard Doran
PSD | President | 63 | 23-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 21-08-29 |
Chairman | 72 | 18-03-14 | |
James McCullough
FOU | Founder | 56 | 18-03-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 25.5 | 0.00% | 83,781 |
24-05-09 | 25.5 | -3.77% | 574,560 |
24-05-08 | 26.5 | 0.00% | 98,300 |
24-05-07 | 26.5 | -3.64% | 400,630 |
24-05-03 | 27.5 | -1.79% | 326,997 |
Delayed Quote London S.E., May 10, 2024 at 11:35 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+64.52% | 49.26M | |
-16.33% | 18.62B | |
+22.02% | 1.94B | |
+0.39% | 1.68B | |
+27.15% | 1.26B | |
-10.70% | 1.03B | |
-18.27% | 938M | |
+0.66% | 783M | |
-25.07% | 628M | |
+14.62% | 535M |
- Stock Market
- Equities
- RENX Stock